Considerations for the Use of Artificial Intelligence to Support Regulatory Decision-Making for Drug and Biological Products Guidance for Industry and Other Interested Parties; Draft Guidance
NonrulemakingOtherFDA-2024-D-4689-0003
Document
Details
The document's own metadata, straight from regulations.gov.
- Posted
- Jan 7, 2025
- Agency
- Food and Drug Administration (FDA)